PTPRD antibody
GTX51104
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetPTPRD
Overview
- SupplierGeneTex
- Product NamePTPRD antibody
- Delivery Days Customer9
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID5789
- Target namePTPRD
- Target descriptionprotein tyrosine phosphatase receptor type D
- Target synonymsHPTP; HPTPD; HPTPDELTA; protein tyrosine phosphatase, receptor type, delta polypeptide; PTPD; rceptor-type tyrosine-protein phosphatase delta; receptor-type tyrosine-protein phosphatase delta; RPTPDELTA; R-PTP-delta
- HostRabbit
- IsotypeIgG
- Protein IDP23468
- Protein NameReceptor-type tyrosine-protein phosphatase delta
- Scientific DescriptionThe protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular region, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this protein is composed of three Ig-like and eight fibronectin type III-like domains. Studies of the similar genes in chicken and fly suggest the role of this PTP is in promoting neurite growth, and regulating neurons axon guidance. Multiple alternatively spliced transcript variants of this gene have been reported. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jan 2010]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes. Chen YT et al., 2016 Jun 28, OncotargetRead more